[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Production and Market of Picoxystrobin in China - Executive Summary

April 2015 | 1 pages | ID: P2810C9A908EN
Guangzhou CCM Information Science & Technology Co., Ltd. (CCM)

US$ 501.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Executive Summary of Production and Market of Picoxystrobin in China is from CCM’s report Production and Market of Picoxystrobin in China, which was finished in April, 2015.

At present, only DuPont has registered the production of picoxystrobin technical in China, while the capacity and output of picoxystrobin in China have been increasing with the expiration of picoxystrobin's patent in 2008.

As for the consumption of picoxystrobin in China, it is mainly used to avoid and cure diseases of vegetables and fruits, and the popular picoxystrobin formulation is 22.5% SC.

It's forecasted that both the output and demand of picoxystrobin will continue to increase at a modest rise in the next five years.

The Executive Summary of Production and Market of Picoxystrobin in China briefs you the production and market of Picoxystrobin in China, showing you the potential of China’s picoxystrobin industry.


More Publications